Loading...

CNSP - CNS Pharmaceuticals, Inc.

Penny Signal for 06-24-2022
Penny Stock Signal: CNSP


Loading Chart CNSP

Stock Signal Information


Signal

Penny Stock Signal: CNSP
Report Date: 06-24-2022
Symbol: CNSP - CNS Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Penny Stock Signal: CNSP

  CNSP Technical Analysis

Company Contact

CNS Pharmaceuticals, Inc. (CNSP)
2100 West Loop S Ste 900
Houston, TEXAS 77027
Phone: 18009469185
Website: https://www.cnspharma.com
CEO: Mr. John Michael Climaco Esq., J.D.

CNSP, CNS Pharmaceuticals, Inc.

CNSP CNS Pharmaceuticals, Inc. Logo Image

NASDAQ, Nasdaq Capital Market


Company Profile

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was founded in 2017 and is based in Houston, Texas.